Monday, September 16, 2019 - 6:00pm to 7:30pm
Dr. Kamel Khalili - From Bench to Bedside: New Breakthroughs in CRISPR Gene Editing and the HIV Virus
A permanent cure for the human immunodeficiency virus (HIV) infection continues to remain elusive, though new treatments and even the potential for a complete cure may soon be within our grasp.
The Franklin Institute’s Speaker Series continues with a groundbreaking discussion with Dr. Kamel Khalili, Chair of the Department of Neuroscience at Temple University. Khalili and his team of researchers made a major breakthrough in 2017 by demonstrating the use of the CRISPR gene editing technique for the treatment of HIV. Khalili’s team successfully utilized CRISPR proteins to completely shut down and eliminate HIV from infected cells in animals, demonstrating incredible potential for complete eradication of the HIV virus in preliminary animal testing.
Dr. Khalili sits down with The Franklin Institute’s chief bioscientist, Dr. Jayatri Das, to discuss the limitations of current treatments for HIV as well as the next steps facing researchers as they aim to take their discovery from bench to bedside—especially in light of a Chinese scientist’s recent controversial application of the CRISPR technique in human babies to address the risk of HIV infection.
Dr. Kamel Khalili is the Laura H. Carnell Professor and Chair in Department of Neuroscience at Temple University. He also serves as director of both the Center for Neurovirology and the Comprehensive NeuroAIDS Center at the Lewis Katz School of Medicine at Temple University. You can read more about Dr. Khalili and his research here. For information on the breakthrough 2017 study led by Dr. Khalili and his team click here.